Trexquant Investment LP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2022$1,009,489
-51.0%
39,885
-62.7%
0.03%
-59.7%
Q3 2022$2,059,000
+108.6%
106,800
+175.7%
0.07%
+63.6%
Q2 2022$987,000
+151.8%
38,740
+154.4%
0.04%
+144.4%
Q1 2022$392,000
-21.6%
15,226
-18.5%
0.02%
-66.0%
Q4 2020$500,000
+7.3%
18,678
+37.6%
0.05%
+76.7%
Q3 2020$466,00013,5750.03%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders